ARDX | ArdelyxNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$3.03
$0.00 (0.00%)

Ardelyx (ARDX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $3.03 vs 50 $3.40 / 200 $5.30
Projection
No cross projected
Test
No active test
Last cross
Death cross 30 Jun 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $3.03 vs 50 $5.42 / 200 $5.30
Projection
Death cross projected in 3 bars
Test
No active test
Last cross
Golden cross week of 11 Dec 2023 ยท projected 29 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $3.05 vs 50 $3.19 / 200 $4.22
Projection
No cross projected
Test
No active test
Last cross
Death cross 19 Mar 2026 ยท projected 30 bars out

Cross history

28
crosses on record since 2018
14 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
30 Jun 2026Death flatdaily30 bars outNot tested
19 Mar 2026Death4-hour30 bars outNot tested
2 Sep 2025Golden steepdaily27 bars outNot tested
4 Aug 2025Golden4-hour30 bars outโ€”
26 Mar 2025Death4-hour6 bars outโ€”

About ARDX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.